Digest Network Come funziona
Network
/
Società
Am
Non verificato

Ambry Genetics

Di cosa scriviamo

BiotecnologiaIndustriaOncologiaSaluteScienza

11 comunicati stampa

Guarda tutti i comunicati
09/06/2026
Tecnica
Scienza
Biotecnologia
Medicina - Varie
Salute
Information Technology
Oncologia
Industria
Genetics in Medicine Open Study Demonstrates How Ambry Genetics’ ExomeReveal® RNA Testing Can Improve Diagnostic Clarity in Exome Testing
Fonte
Ambry Genetics
Emittente
Business Wire
1.00
0
11/05/2026
Eventi
Scienza
Oncologia
Salute
Tecnica
Biotecnologia
Ambry Genetics’ CARE Program® Wins 2026 MedTech Breakthrough Award for “Best Overall Health Informatics Solution”
Fonte
Ambry Genetics
Emittente
Business Wire
1.00
0
04/02/2026
Mercato del lavoro
Industria
Scienza
Biotecnologia
Farmaceutica
Oncologia
Sanità
Salute
Ambry’s Contributions to MAVEs Support Thousands of Patient Reclassifications and Expand to New Genes
Fonte
Ambry Genetics
Emittente
Business Wire
1.00
0
02/02/2026
Scienza
Biotecnologia
Salute
Attrezzature medico-sanitarie
Tecnica
Industria
Ambry Genetics Announces One Millionth Test Leveraging RNA to Improve Diagnostic Accuracy and Yield
Fonte
Ambry Genetics
Emittente
Business Wire
1.00
0
20/10/2025
Biotecnologia
Salute
Scienza
Analisi di mercato
Industria
Ambry Genetics Announces 10-Year Study in Genetics in Medicine Highlighting the Impact of Proactive Exome Reanalysis for Healthcare Equity
Fonte
Ambry Genetics
Emittente
Business Wire
1.00
0
01/10/2025
Tecnica
Igiene alimentare
Salute
Medicina nucleare
Associazioni/Professionisti
Oncologia
Scienza
Attrezzature medico-sanitarie
Sanità
Industria
Ambry Genetics Announces Improved EHR-Integrated Breast Cancer Risk Assessment Solution with Upgraded Tyrer-Cuzick Scoring Approach Incorporating Breast Density
Fonte
Ambry Genetics
Emittente
Business Wire
1.00
0
25/06/2025
Information Technology
Biotecnologia
Tecnica
Salute
Oncologia
Scienza
Medicina - Varie
Industria
Ambry Genetics’ CARE Program Validated for Accuracy in Identifying High-Risk Patients for Hereditary Cancer Testing
Fonte
Ambry Genetics
Emittente
Business Wire
1.00
0
27/05/2025
Information Technology
Biotecnologia
Tecnica
Salute
Scienza
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Industria
New Study Shows Impact of Ambry Genetics’ Patient for Life™ Program on Rare Disease Diagnosis
Fonte
Ambry Genetics
Emittente
Business Wire
1.00
0
08/01/2025
Analisi di mercato
Scienza
Sanità
Oncologia
Information Technology
Tecnica
Biotecnologia
Medicina - Varie
Salute
Ambry Genetics Data Supports Functional Study of BRCA2, Helping Improve Variant Classification for Hereditary BRCA2-Linked Cancers
Fonte
Ambry Genetics
Emittente
Business Wire
1.00
0
17/09/2024
Eventi
Fiere
Industria
Biotecnologia
Salute
Sanità
Farmaceutica
Oncologia
Scienza
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Ambry Genetics Announces New Hereditary Cancer Test Menu at NSGC Annual Conference
Fonte
Ambry Genetics
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0